Basic Abilify Information

• International Nonproprietary Name (INN): Aripiprazole
• Brand names available in Canada: Abilify
• ATC Code: N05AX12
• Forms & dosages: Tablets (2 mg, 5 mg, 10 mg, 15 mg, 20 mg, 30 mg), oral solution, injectable (Maintena, Asimtufii)
• Manufacturers in Canada: Otsuka Pharmaceutical, Lundbeck
• Registration status in Canada: Rx
• OTC / Rx classification: Prescription-only (Rx)

Everyday Use & Best Practices

For anyone prescribed Abilify, consistency in timing is key to maximising benefits. Whether it's taken in the morning or evening, sticking to a routine can help maintain steady levels of the medication in your bloodstream. Patients often find that morning doses work better with their daily activities and productivity. On the other hand, some may prefer taking it in the evening to support better sleep or to reduce daytime drowsiness.

When integrating Abilify into daily schedules, consider your lifestyle:

• Morning routines may include taking the medication with breakfast, fitting in with typical Canadian diets of eggs, toast, or oatmeal.
• If opting for evening dosing, ensure that it aligns with your wind-down activities to reduce potential restlessness.
• Set reminders on your phone to maintain consistency and avoid missed doses, as this can affect the medication's efficacy.

Taking With or Without Meals (Canadian Diet Context)

How you take Abilify—whether with food or on an empty stomach—can influence how well it works. For optimal absorption, taking it with a meal is often recommended. This is particularly relevant given Canadian dietary habits that typically include substantial breakfasts or dinners.

Common breakfast options like whole grain toast with avocado, yogurt with fruit, or even a smoothie can pair well with Abilify, without affecting the medication's absorption negatively. Other meals or snacks throughout the day should also consider similar substantial nutritional content.

Overall, managing when to take Abilify in conjunction with meals can help mitigate some common side effects such as nausea or upset stomach, supporting a smoother experience with the medication.

Safety Priorities

Who should avoid it (Health Canada advisories)

Health Canada has laid down crucial advisories regarding the use of Abilify, especially for certain populations. It's important for patients with the following conditions to approach Abilify with caution or avoid it altogether:

• Known hypersensitivity to aripiprazole or any ingredient in the formulation.
• Individuals with a history of cardiovascular issues, as Abilify can pose risks like QT prolongation affecting heart rhythm.
• Those with a history of seizures should also exercise caution, as the medication can lower the seizure threshold.
• Patients with diabetes may face an increased risk of hyperglycemia when taking this medication.
• For older adults experiencing dementia-related psychosis, there's a notably increased risk of mortality associated with its use.

Health Canada stresses that any use in pregnant or lactating women should only occur if the benefits clearly outweigh the risks, emphasizing careful monitoring and consultation with a healthcare provider.

Activities to limit (driving, workplace safety)

While taking Abilify, it’s wise to consider how its side effects might impact daily activities, especially driving and workplace safety. Common side effects such as drowsiness, dizziness, and akathisia (a state of restlessness) can make operating a vehicle or heavy machinery hazardous.

Canadians on Abilify should be aware of the following:

• If any sedation or impaired coordination is experienced, avoid driving until these effects have resolved.
• In a workplace setting, operating heavy machinery or performing tasks requiring precise coordination can also pose risks.
• It’s advisable for individuals to communicate openly with employers and discuss any medication effects that might influence their job performance.

Using Abilify effectively needs an emphasis on safety. Always consult healthcare providers about the implications of any side effects while considering commuting, work responsibilities, or participating in activities that demand full focus. This vigilance promotes safer environments for everyone, particularly for those who may be directly affected by medication-induced impairments.

Dosage & Adjustments

General regimen (DIN references)

When it comes to Abilify, adhering to the right dosage is pivotal for optimal results. Health Canada's guidelines recommend a variety of standard dosages depending on the condition being treated:

• Schizophrenia: 10–15 mg daily, ranging up to 30 mg.
• Bipolar I disorder: Start at 15 mg daily.
• Major Depressive Disorder (adjunct treatment): Begin with 2-5 mg daily.
• Tourette’s Disorder: Typically not first-line but can be started at 2 mg for children 6–17 years old.
• Autistic Irritability: Dosing can reach up to 15 mg for the same age group.

For patient reference, directors looking to verify specific medication details can find Abilify with the Drug Identification Number (DIN) 02267221 for tablets, 02267239 for the oral solution, and 02269251 for the injectable form.

Special cases (elderly, comorbidities)

Administering Abilify in special populations necessitates caution. The elderly, due to possible comorbidities, generally require:

• Lower initial dosages: This helps mitigate the increased risk of adverse reactions, particularly amongst those with dementia-related conditions.
• Cautious titration: Gradual increases ensure that potential side effects are monitored closely.

Furthermore, individuals with co-existing health conditions, such as liver or renal impairments, may require tailored adjustments. For those with liver issues, Abilify should be approached carefully, particularly in severe hepatic impairment cases, while renal adjustments may not always be necessary but should still consider the patient's overall health. The aim is to strike a balance between therapeutic efficacy and patient safety.